Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05659524 · ClinicalTrials.gov registry record · NA

Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery

A NA study of Pituitary Tumor, sponsored by Lori Wood.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
2
Study locations

NCT05659524 is a NA study of Pituitary Tumor that is actively recruiting participants, run by Lori Wood. The registered enrollment target is 140 participants, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05659524, a NA study of Pituitary Tumor, is actively recruiting participants, sponsored by Lori Wood.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.

Conditions Studied

Interventions

  • OTHER Nasal saline irrigation

Study Locations (2)

Arizona

  • Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2020-12-18
Est. Completion 2029-12-31
Phase NA

Sponsor

Lori Wood

1 total trials

What the Registry Record Tells You About NCT05659524

The ClinicalTrials.gov registry entry for NCT05659524 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower). The listed sponsor is Lori Wood, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pituitary Tumor appearing as the primary indexed condition, and to 1 intervention - of which Nasal saline irrigation is the first listed.

NCT05659524 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Ohio.

Frequently Asked Questions

What is clinical trial NCT05659524 about?

NCT05659524 is a clinical study titled "Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery". This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes f...

What is the current status of trial NCT05659524?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2020-12-18. Estimated completion is 2029-12-31.

What conditions does trial NCT05659524 study?

This clinical trial studies the following conditions: Pituitary Tumor.

What interventions are being tested in trial NCT05659524?

The interventions under investigation include: Nasal saline irrigation (OTHER).

Who is sponsoring clinical trial NCT05659524?

This trial is sponsored by Lori Wood, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05659524 being conducted?

This trial has 2 study locations across Arizona, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pituitary Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.